LipidII: Just Another Brick in the Wall?

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Scheffers, Dirk Jan ^a   Tol, Menno B ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID II; MEMBRANE LIPID; MEMBRANE PROTEIN; PENICILLIN BINDING PROTEIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ANTIBACTERIAL ACTIVITY; BACILLUS SUBTILIS; BACTERIUM MUTANT; BIOINFORMATICS; CELL MEMBRANE; CELLULAR DISTRIBUTION; CYTOPLASM; ENZYME SUBSTRATE; FLUORESCENCE MICROSCOPY; LIPID ANALYSIS; MEMBRANE STRUCTURE; NONHUMAN; REVIEW; TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPY; CELL WALL; METABOLISM;

BACTERIAL PROTEINS; CELL WALL; PEPTIDOGLYCAN;

EID: 84953326972     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005213     Document Type: Review

References (71)

1. Schneider T, Sahl HG, An oldie but a goodie—cell wall biosynthesis as antibiotic target pathway. IJMM. 2010;300(2–3):161–9. doi: 10.1016/j.ijmm.2009.10.005 20005776
2. Johnson JW, Fisher JF, Mobashery S, Bacterial cell-wall recycling. Ann NY Acad Sci. 2013;1277(1):54–75.
3. Lovering AL, Safadi SS, Strynadka NC, Structural perspective of peptidoglycan biosynthesis and assembly. Annu Rev Biochem. 2012;81:451–78. doi: 10.1146/annurev-biochem-061809-112742 22663080
4. Typas A, Banzhaf M, Gross CA, Vollmer W, From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat Rev Microbiol. 2012;10(2):123–36.
5. Turner RD, Vollmer W, Foster SJ, Different walls for rods and balls: the diversity of peptidoglycan. Mol Microbiol. 2014;91(5):862–74. doi: 10.1111/mmi.12513 24405365
6. Bugg TD, Braddick D, Dowson CG, Roper DI, Bacterial cell wall assembly: still an attractive antibacterial target. Trends Biotechnol. 2011;29(4):167–73. doi: 10.1016/j.tibtech.2010.12.006 21232809
7. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517(7535):455–9. doi: 10.1038/nature14098 25561178
8. Breukink E, de Kruijff B, Lipid II as a target for antibiotics. Nat Rev Drug Discov. 2006;5(4):321–32. 16531990
9. Liechti GW, Kuru E, Hall E, Kalinda A, Brun YV, VanNieuwenhze M, et al. A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature. 2014;506(7489):507–10. doi: 10.1038/nature12892 24336210
10. Pilhofer M, Aistleitner K, Biboy J, Gray J, Kuru E, Hall E, et al. Discovery of chlamydial peptidoglycan reveals bacteria with murein sacculi but without FtsZ. Nat Commun. 2013;4:2856. doi: 10.1038/ncomms3856 24292151
11. Henrichfreise B, Schiefer A, Schneider T, Nzukou E, Poellinger C, Hoffmann TJ, et al. Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed? Molecular Microbiology. 2009;73(5):913–23. doi: 10.1111/j.1365-2958.2009.06815.x 19656295
12. Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, et al. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science. 1999;284(5413):507–11. 10205063
13. Galley NF, O'Reilly AM, Roper DI, Prospects for novel inhibitors of peptidoglycan transglycosylases. Bioorg Chem. 2014;55:16–26. doi: 10.1016/j.bioorg.2014.05.007 24924926
14. Münch D, Sahl HG, Structural variations of the cell wall precursor lipid II in Gram-positive bacteria—Impact on binding and efficacy of antimicrobial peptides. Biochim Biophys Acta. 2015; 1848(11 Pt B):3062–71. doi: 10.1016/j.bbamem.2015.04.014 25934055
15. Draper LA, Cotter PD, Hill C, Ross RP, Lantibiotic resistance. Microbiol Mol Biol Rev. 2015;79(2):171–91. doi: 10.1128/MMBR.00051-14 25787977
16. Bionda N, Pitteloud JP, Cudic P, Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria. Future Med Chem. 2013;5(11):1311–30. doi: 10.4155/fmc.13.86 23859209
17. Knerr PJ, van der Donk WA, Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem. 2012;81:479–505. doi: 10.1146/annurev-biochem-060110-113521 22404629
18. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, et al. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol. 2004;11(10):963–7. 15361862
19. Bonev BB, Breukink E, Swiezewska E, De Kruijff B, Watts A, Targeting extracellular pyrophosphates underpins the high selectivity of nisin. FASEB J. 2004;18(15):1862–9. 15576489
20. Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 2006;313(5793):1636–7. 16973881
21. Tol MB, Morales Angeles D, Scheffers DJ, In Vivo Cluster Formation of Nisin and Lipid II Is Correlated with Membrane Depolarization. Antimicrob Agents Chemother. 2015;59(6):3683–6. doi: 10.1128/AAC.04781-14 25870072
22. Wiedemann I, Bottiger T, Bonelli RR, Wiese A, Hagge SO, Gutsmann T, et al. The mode of action of the lantibiotic lacticin 3147—a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol. 2006;61(2):285–96. 16771847
23. Oman TJ, Lupoli TJ, Wang TS, Kahne D, Walker S, van der Donk WA, Haloduracin alpha binds the peptidoglycan precursor lipid II with 2:1 stoichiometry. J Am Chem Soc. 2011;133(44):17544–7. doi: 10.1021/ja206281k 22003874
24. Breukink E, A lesson in efficient killing from two-component lantibiotics. Mol Microbiol. 2006;61(2):271–3. 16771845
25. Munch D, Muller A, Schneider T, Kohl B, Wenzel M, Bandow JE, et al. The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem. 2014;289(17):12063–76. doi: 10.1074/jbc.M113.537449 24627484
26. Foulston LC, Bibb MJ, Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes. Proc Natl Acad Sci U S A. 2010;107(30):13461–6. doi: 10.1073/pnas.1008285107 20628010
27. Leclercq R, Derlot E, Duval J, Courvalin P, Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3):157–61. 2968517
28. Henriques AO, Glaser P, Piggot PJ, P MC Jr.Control of cell shape and elongation by the rodA gene in Bacillus subtilis. Mol Microbiol. 1998;28(2):235–47. 9622350
29. Wang L, Khattar MK, Donachie WD, Lutkenhaus J, FtsI and FtsW are localized to the septum in Escherichia coli. J Bacteriol. 1998;180(11):2810–6. 9603865
30. Khattar MM, Begg KJ, Donachie WD, Identification of FtsW and characterization of a new ftsW division mutant of Escherichia coli. J Bacteriol. 1994;176(23):7140–7. 7961485
31. van der Ploeg R, Goudelis S, den Blaauwen T, Validation of FRET Assay for the Screening of Growth Inhibitors of Escherichia coli Reveals Elongasome Assembly Dynamics. Int J Mol Sci. 2015;16(8):17637–54. doi: 10.3390/ijms160817637 26263980
32. de Pedro MA, Donachie WD, Höltje JV, Schwarz H, Constitutive septal murein synthesis in Escherichia coli with impaired activity of the morphogenetic proteins RodA and penicillin-binding protein 2. J Bacteriol. 2001;183(14):4115–26. 11418550
33. Mohammadi T, van Dam V, Sijbrandi R, Vernet T, Zapun A, Bouhss A, et al. Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane. EMBO J. 2011;30(8):1425–32. doi: 10.1038/emboj.2011.61 21386816
34. Mohammadi T, Sijbrandi R, Lutters M, Verheul J, Martin NI, den Blaauwen T, et al. Specificity of the transport of lipid II by FtsW in Escherichia coli. J Biol Chem. 2014;289(21):14707–18. doi: 10.1074/jbc.M114.557371 24711460
35. Ruiz N, Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc Natl Acad Sci U S A. 2008;105(40):15553–7. doi: 10.1073/pnas.0808352105 18832143
36. Inoue A, Murata Y, Takahashi H, Tsuji N, Fujisaki S, Kato J, Involvement of an essential gene, mviN, in murein synthesis in Escherichia coli. J Bacteriol. 2008;190(21):7298–301. doi: 10.1128/JB.00551-08 18708495
37. Mohamed YF, Valvano MA, A Burkholderia cenocepacia MurJ (MviN) homolog is essential for cell wall peptidoglycan synthesis and bacterial viability. Glycobiology. 2014;24(6):564–76. doi: 10.1093/glycob/cwu025 24688094
38. Butler EK, Davis RM, Bari V, Nicholson PA, Ruiz N, Structure-function analysis of MurJ reveals a solvent-exposed cavity containing residues essential for peptidoglycan biogenesis in Escherichia coli. J Bacteriol. 2013;195(20):4639–49. doi: 10.1128/JB.00731-13 23935042
39. Butler EK, Tan WB, Joseph H, Ruiz N, Charge requirements of lipid II flippase activity in Escherichia coli. J Bacteriol. 2014;196(23):4111–9. doi: 10.1128/JB.02172-14 25225268
40. Sham LT, Butler EK, Lebar MD, Kahne D, Bernhardt TG, Ruiz N, Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science. 2014;345(6193):220–2. doi: 10.1126/science.1254522 25013077
41. Fay A, Dworkin J, Bacillus subtilis homologs of MviN (MurJ), the putative Escherichia coli lipid II flippase, are not essential for growth. J Bacteriol. 2009;191(19):6020–8. doi: 10.1128/JB.00605-09 19666716
42. Meeske AJ, Sham LT, Kimsey H, Koo BM, Gross CA, Bernhardt TG, et al. MurJ and a novel lipid II flippase are required for cell wall biogenesis in Bacillus subtilis. Proc Natl Acad Sci U S A. 2015; 112(20):6437–42. doi: 10.1073/pnas.1504967112 25918422
43. Schirner K, Eun YJ, Dion M, Luo Y, Helmann JD, Garner EC, et al. Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB. Nat Chem Biol. 2015;11(1):38–45. doi: 10.1038/nchembio.1689 25402772
44. Garner EC, Bernard R, Wang W, Zhuang X, Rudner DZ, Mitchison T, Coupled, circumferential motions of the cell wall synthesis machinery and MreB filaments in B. subtilis. Science. 2011;333(6039):222–5. doi: 10.1126/science.1203285 21636745
45. Dominguez-Escobar J, Chastanet A, Crevenna AH, Fromion V, Wedlich-Soldner R, Carballido-Lopez R, Processive movement of MreB-associated cell wall biosynthetic complexes in bacteria. Science. 2011;333(6039):225–8. doi: 10.1126/science.1203466 21636744
46. Lee YH, Helmann JD, Reducing the Level of Undecaprenyl Pyrophosphate Synthase Has Complex Effects on Susceptibility to Cell Wall Antibiotics. Antimicrob Agents Chemother. 2013;57(9):4267–75.
47. Muchova K, Wilkinson AJ, Barak I, Changes of lipid domains in Bacillus subtilis cells with disrupted cell wall peptidoglycan. FEMS Microbiol Lett. 2011;325(1):92–8. doi: 10.1111/j.1574-6968.2011.02417.x 22092867
48. Strahl H, Burmann F, Hamoen LW, The actin homologue MreB organizes the bacterial cell membrane. Nat Commun. 2014;5:3442. doi: 10.1038/ncomms4442 24603761
49. Ganchev DN, Hasper HE, Breukink E, de Kruijff B, Size and orientation of the lipid II headgroup as revealed by AFM imaging. Biochemistry. 2006;45(19):6195–202. 16681392
50. Donovan C, Bramkamp M, Characterization and subcellular localization of a bacterial flotillin homologue. Microbiology. 2009;155:1786–99. doi: 10.1099/mic.0.025312-0 19383680
51. Lopez D, Kolter R, Functional microdomains in bacterial membranes. Genes Dev. 2010;24(17):1893–902. doi: 10.1101/gad.1945010 20713508
52. Bach JN, Bramkamp M, Flotillins functionally organize the bacterial membrane. Mol Microbiol. 2013;88(6):1205–17. doi: 10.1111/mmi.12252 23651456
53. Daniel RA, Errington J, Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell. 2003;113:767–76. 12809607
54. Yepes A, Koch G, Waldvogel A, Garcia-Betancur JC, Lopez D, Reconstruction of mreB expression in Staphylococcus aureus via a collection of new integrative plasmids. Appl Environ Microbiol. 2014;80(13):3868–78. doi: 10.1128/AEM.00759-14 24747904
55. Defeu Soufo HJ, Graumann PL, Bacillus subtilis actin-like protein MreB influences the positioning of the replication machinery and requires membrane proteins MreC/D and other actin-like proteins for proper localization. BMC Cell Biol. 2005;6(1):10. 15745453
56. White CL, Kitich A, Gober JW, Positioning cell wall synthetic complexes by the bacterial morphogenetic proteins MreB and MreD. Molecular Microbiology. 2010;76(3):616–33. doi: 10.1111/j.1365-2958.2010.07108.x 20233306
57. Alyahya SA, Alexander R, Costa T, Henriques AO, Emonet T, Jacobs-Wagner C, RodZ, a component of the bacterial core morphogenic apparatus. Proc Natl Acad Sci U S A. 2009;106(4):1239–44. doi: 10.1073/pnas.0810794106 19164570
58. Bendezu FO, Hale CA, Bernhardt TG, de Boer PA, RodZ (YfgA) is required for proper assembly of the MreB actin cytoskeleton and cell shape in E. coli. EMBO J. 2009;28(3):193–204. doi: 10.1038/emboj.2008.264 19078962
59. Shiomi D, Sakai M, Niki H, Determination of bacterial rod shape by a novel cytoskeletal membrane protein. EMBO J. 2008;27:3081–91. doi: 10.1038/emboj.2008.234 19008860
60. van Teeffelen S, Wang S, Furchtgott L, Huang KC, Wingreen NS, Shaevitz JW, et al. The bacterial actin MreB rotates, and rotation depends on cell-wall assembly. Proc Natl Acad Sci U S A. 2011;108(38):15822–7. doi: 10.1073/pnas.1108999108 21903929
61. Salje J, van den Ent F, de Boer P, Lowe J, Direct membrane binding by bacterial actin MreB. Mol Cell. 2011;43(3):478–87. doi: 10.1016/j.molcel.2011.07.008 21816350
62. van den Ent F, Izore T, Bharat TA, Johnson CM, Lowe J, Bacterial actin MreB forms antiparallel double filaments. eLife. 2014;3:e02634. doi: 10.7554/eLife.02634 24843005
63. Maeda YT, Nakadai T, Shin J, Uryu K, Noireaux V, Libchaber A, Assembly of MreB filaments on liposome membranes: a synthetic biology approach. ACS synthetic biology. 2012;1(2):53–9. doi: 10.1021/sb200003v 23651045
64. Szwedziak P, Lowe J, Do the divisome and elongasome share a common evolutionary past? Curr Opin Microbiol. 2013;16(6):745–51. doi: 10.1016/j.mib.2013.09.003 24094808
65. Scheffers DJ, Pinho MG, Bacterial cell wall synthesis: new insights from localization studies. Microb Mol Biol Rev. 2005;69(4):585–607.
66. Pinho MG, Errington J, Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates. Mol Microbiol. 2005;55(3):799–807. 15661005
67. Morlot C, Noirclerc-Savoye M, Zapun A, Dideberg O, Vernet T, The carboxypeptidase PBP3 organizes the division process of Streptococcus pneumoniae. Mol Microbiol. 2004;51(6):1641–8. 15009891
68. Barendt SM, Sham LT, Winkler ME, Characterization of mutants deficient in the L,D-carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of Streptococcus pneumoniae serotype 2 strain D39. J Bacteriol. 2011;193(9):2290–300. doi: 10.1128/JB.01555-10 21378199
69. Potluri L, Karczmarek A, Verheul J, Piette A, Wilkin JM, Werth N, et al. Septal and lateral wall localization of PBP5, the major D,D-carboxypeptidase of Escherichia coli, requires substrate recognition and membrane attachment. Mol Microbiol. 2010;77(2):300–23. doi: 10.1111/j.1365-2958.2010.07205.x 20545860
70. Costa T, Priyadarshini R, Jacobs-Wagner C, Localization of PBP3 in Caulobacter crescentus is highly dynamic and largely relies on its functional transpeptidase domain. Mol Microbiol. 2008;70(3):634–51. doi: 10.1111/j.1365-2958.2008.06432.x 18786147
71. Lages MC, Beilharz K, Morales Angeles D, Veening JW, Scheffers DJ, The localization of key Bacillus subtilis penicillin binding proteins during cell growth is determined by substrate availability. Env Microbiol. 2013;15(12):3272–81.